STATE OF WISCONSIN INVESTMENT BOARD - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 171 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE OF WISCONSIN INVESTMENT BOARD ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q1 2023$82,410
-76.7%
51,830
-8.5%
0.00%
-100.0%
Q4 2022$352,967
+8.9%
56,656
+17.1%
0.00%0.0%
Q3 2022$324,000
-63.1%
48,392
-65.0%
0.00%
-50.0%
Q2 2022$879,000
+77.9%
138,257
+29.8%
0.00%
+100.0%
Q1 2022$494,000
+17.9%
106,500
+206.0%
0.00%0.0%
Q3 2021$419,000
-43.1%
34,8000.0%0.00%
-50.0%
Q2 2021$736,000
-24.6%
34,8000.0%0.00%0.0%
Q1 2021$976,000
+1.5%
34,800
-5.9%
0.00%0.0%
Q4 2020$962,000
-37.8%
37,000
-11.1%
0.00%
-50.0%
Q3 2020$1,546,000
-23.5%
41,600
+5.6%
0.00%
-33.3%
Q2 2020$2,022,000
+64.0%
39,400
+0.8%
0.01%
+50.0%
Q1 2020$1,233,000
-44.7%
39,100
+4.5%
0.00%
-33.3%
Q4 2019$2,230,000
+62.7%
37,4000.0%0.01%
+50.0%
Q3 2019$1,371,000
-9.3%
37,400
+15.1%
0.00%0.0%
Q2 2019$1,512,000
+18.4%
32,500
+2.2%
0.00%0.0%
Q1 2019$1,277,000
+18.7%
31,800
+35.9%
0.00%0.0%
Q4 2018$1,076,000
+4.1%
23,400
+0.4%
0.00%
+33.3%
Q3 2018$1,034,000
+13.3%
23,3000.0%0.00%0.0%
Q2 2018$913,000
-25.8%
23,300
+37.1%
0.00%
-25.0%
Q1 2018$1,230,000
+69.9%
17,000
+54.5%
0.00%
+100.0%
Q4 2017$724,000
+31.4%
11,0000.0%0.00%0.0%
Q3 2017$551,000
+8.3%
11,0000.0%0.00%0.0%
Q2 2017$509,00011,0000.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q1 2023
NameSharesValueWeighting ↓
Meditor Group Ltd 2,679,835$99,609,00022.32%
Bellevue Group AG 5,465,715$203,160,0002.81%
Rhenman & Partners Asset Management AB 455,000$16,912,0001.50%
Endurant Capital Management LP 135,901$5,051,0001.49%
Boxer Capital, LLC 975,000$36,241,0001.25%
DCF Advisers, LLC 56,500$2,100,0001.07%
Pentwater Capital Management LP 2,169,022$80,623,0001.04%
Nicholas Investment Partners, LP 235,855$8,767,0000.95%
Amia Capital LLP 20,464$761,0000.88%
HAMILTON LANE ADVISORS LLC 46,181$1,717,0000.83%
View complete list of ESPERION THERAPEUTICS INC NE shareholders